Cargando…
MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro
Colorectal cancer is one of the most common malignancies. Aberrant expressed microRNAs (miRNAs) have been demonstrated to have strong associations with colorectal cancer by repressing their targets. Therefore, miRNAs are thought to have significant promise in the diagnosis and prognosis of colorecta...
Autores principales: | Liu, Jingtian, Chen, Zongyou, Xiang, Jianbin, Gu, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844014/ https://www.ncbi.nlm.nih.gov/pubmed/29556299 http://dx.doi.org/10.3892/ol.2018.8069 |
Ejemplares similares
-
Myeloid-Derived Suppressor Cells Participate in Preventing Graft Rejection
por: Wang, Yan, et al.
Publicado: (2012) -
MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1
por: Peng, Yang, et al.
Publicado: (2015) -
The microRNA-200 family acts as an oncogene in colorectal cancer by inhibiting the tumor suppressor RASSF2
por: Carter, Jane V., et al.
Publicado: (2019) -
MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma
por: Hübner, Max, et al.
Publicado: (2020) -
MicroRNA-155 expression with Brucella infection in vitro and in vivo and decreased serum levels of MicroRNA-155 in patients with brucellosis
por: Zhang, Xi, et al.
Publicado: (2022)